(Q34506664)

English

Human monoclonal antibodies against glucagon receptor improve glucose homeostasis by suppression of hepatic glucose output in diet-induced obese mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Human monoclonal antibodies against glucagon receptor improve glucose homeostasis by suppression of hepatic glucose output in diet-induced obese mice (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

Yong-ho Lee

2

0 references

author name string

Wook-Dong Kim

1

1 reference

Europe PubMed Central

2 August 2017

Min-Hee Kim

3

1 reference

Europe PubMed Central

2 August 2017

Sun-Young Jung

4

1 reference

Europe PubMed Central

2 August 2017

Woo-Chan Son

5

1 reference

Europe PubMed Central

2 August 2017

Seon-Joo Yoon

6

1 reference

Europe PubMed Central

2 August 2017

Byung-Wan Lee

7

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

3 December 2012

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

7

1 reference

Europe PubMed Central

2 August 2017

12

1 reference

Europe PubMed Central

2 August 2017

e50954

1 reference

Europe PubMed Central

2 August 2017

copyright license

Creative Commons Attribution 4.0 International

3 December 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Glucolipotoxicity in Pancreatic β-Cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

The role of dysregulated glucagon secretion in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

The prediabetic period: review of clinical aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

New beta-alanine derivatives are orally available glucagon receptor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Alpha cell function in health and disease: influence of glucagon-like peptide-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Islet adaptation to insulin resistance: mechanisms and implications for intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

Glucagon physiology and pathophysiology in the light of new advances

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

7 July 2018

A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050954

21 January 2018

Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050954

21 January 2018

Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050954

21 January 2018

Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050954

21 January 2018

Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050954

21 January 2018

A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050954

21 January 2018

Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0050954

21 January 2018

Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513295

27 October 2018

Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23226550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23226550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23226550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0050954

1 reference

Europe PubMed Central

2 August 2017

2012PLoSO...750954K

0 references

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34506664&oldid=1951508049"